S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.16%) $0.928
USD/NOK
(0.31%) $10.88
USD/GBP
(0.00%) $0.792
USD/RUB
(0.03%) $92.61

Realtime updates for Impel Pharmaceuticals [IMPL]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated20 Dec 2023 @ 15:58

-27.27% $ 0.0400

Live Chart Being Loaded With Signals

Commentary (20 Dec 2023 @ 15:58):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States...

Stats
Today's Volume 720 030
Average Volume 1.02M
Market Cap 956 000
EPS $0 ( 2024-03-22 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0128
ATR14 $0.116 (114.74%)
Insider Trading
Date Person Action Amount type
2023-12-18 Smith Brandon D Buy 0
2023-12-15 Vivo Capital Viii, Llc Sell 87 934 Common Stock
2023-12-18 Vivo Capital Viii, Llc Sell 209 029 Common Stock
2023-12-19 Vivo Capital Viii, Llc Sell 208 657 Common Stock
2023-12-15 Vivo Capital Viii, Llc Sell 12 066 Common Stock
INSIDER POWER
47.76
Last 95 transactions
Buy: 8 739 782 | Sell: 5 181 184

Volume Correlation

Long: 0.42 (neutral)
Short: -0.39 (neutral)
Signal:(41.758) Neutral

Impel Pharmaceuticals Correlation

10 Most Positive Correlations
FNWB0.921
EGBN0.909
CNSL0.904
DIBS0.901
ALTO0.896
FTXO0.892
FFIC0.885
FRST0.883
CSTE0.881
CCSI0.88
10 Most Negative Correlations
LMNR-0.937
WIRE-0.927
NRDS-0.918
MHUA-0.893
PEGA-0.892
SKYT-0.889
OBT-0.889
MORF-0.886
HTBI-0.884
HUGE-0.882

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Impel Pharmaceuticals Correlation - Currency/Commodity

The country flag 0.57
( weak )
The country flag 0.67
( moderate )
The country flag 0.00
( neutral )
The country flag 0.56
( weak )
The country flag 0.65
( moderate )
The country flag -0.50
( weak negative )

Impel Pharmaceuticals Financials

Annual 2022
Revenue: $12.65M
Gross Profit: $6.16M (48.66 %)
EPS: $-5.52
Q3 2023
Revenue: $5.02M
Gross Profit: $2.79M (55.60 %)
EPS: $-0.580
Q2 2023
Revenue: $6.58M
Gross Profit: $3.36M (51.09 %)
EPS: $-0.310
Q1 2023
Revenue: $4.37M
Gross Profit: $2.09M (47.74 %)
EPS: $-1.630

Financial Reports:

No articles found.

Impel Pharmaceuticals

Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105, an upper nasal formulation of olanzapine for the acute treatment of agitation and aggression in autism spectrum disorder; and INP107, an upper nasal formulation of carbidopa/levodopa, which has completed Phase IIa clinical trial for the treatment of OFF episodes in Parkinson's disease. Impel Pharmaceuticals Inc. was formerly known as Impel NeuroPharma, Inc. and changed its name to Impel Pharmaceuticals Inc. in April 2022. Impel Pharmaceuticals Inc. was incorporated in 2008 and is headquartered in Seattle, Washington.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators